CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Biom Up SA is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Biom Up SA
Parc Technologique de Lyon
8, allee Irene Joliot Curie
Phone: +33 486573610p:+33 486573610 Saint-Priest, 69800  France Fax: +33 437690084f:+33 437690084
Filed for Reorganization Proceedings on 10/30/2019
On 10/30/2019, the Lyon Commercial Court initiated a Reorganization Procedure (Redressement Judiciaire) for Biom Up SA following the Chief Executive Officer of the Company, Patrice Ferrand, declaring a Suspension of Payments (Cessation des Paiements). The Court appointed Maître Eric Bauland of SELARL BCM as Administrator (Administrateur Judiciaire).
This company is no longer actively traded on any major stock exchange.
Business Summary
Biom Up SA is a France-based company engaged in the design, development and production of medical devices. The products of the Company are based on biopolymers such as collagen. Biom Up SA markets two lines of products: Cova line (including Cova ORTHO, Cova CARD and Cova MAX, among others), which is a membrane for adhesion prevention and guided healing, and MatriBONE, which is a bone regeneration matrix with haemostatic, absorbable and osteoconductive properties. MatriBONE is used in orthopedic and maxillofacial surgery for the filling of bone defects whether it is from surgical, traumatic or pathological origin. The Company also designs other products, such as dental surgery products and several collagen types, which are developed and manufactured for the Company's partners.
(Source: Company's Website)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/201812/31/2018Yes----

Industries
SIC Code Description
3842 Orthopedic, prosthetic, and surgical appliances and supplies

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board Jan K.Ohrstrom 61 9/18/2019
Chief Executive Officer PatriceFerrand 9/18/2019 9/18/2019
Chief Financial Officer EvelyneNguyen 50 9/18/2019 9/18/2019
12 additional Officers and Directors records available in full report.

General Information
Number of Employees: 104 (As of 12/31/2018)
Outstanding Shares: 14,243,242 (As of 12/31/2018)
Stock Exchange: EPA
Fax Number: +33 437690084


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Friday, July 21, 2023